Clinical usefulness of a bolus calculator in maintaining normoglycaemia in active professional patients with type 1 diabetes treated with continuous subcutaneous insulin infusion

Journal of International Medical Research

Volumn 36, Issue 5, 2008, Pages 1112-1116

  Klupa, Tomasz ^a   Benbenek Klupa, T ^b   Malecki, M ^a   Szalecki, M ^c   Sieradzki, J ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

^b Medtronic Poland   (Poland)

^c Children's Hospital   (Poland)

Author keywords

Blood glucose level; Bolus calculator; Continuous subcutaneous insulin infusion; Diabetes; Insulin PUMF; Post prandial

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; INSULIN ASPART; INSULIN LISPRO; GLYCOSYLATED HEMOGLOBIN; INSULIN;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; BOLUS INJECTION; CLINICAL ARTICLE; CONTINUOUS INFUSION; CONTROLLED STUDY; DISEASE DURATION; DOSE CALCULATION; DRUG EFFICACY; FEMALE; GLUCOSE BLOOD LEVEL; HEMOGLOBIN BLOOD LEVEL; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; MALE; METABOLIC REGULATION; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; DAILY LIFE ACTIVITY; INSULIN INFUSION; METABOLISM; MIDDLE AGED; POSTPRANDIAL STATE; QUALITY OF LIFE; SUBCUTANEOUS DRUG ADMINISTRATION;

ACTIVITIES OF DAILY LIVING; ADULT; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; DIABETES MELLITUS, TYPE 1; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; INJECTIONS, SUBCUTANEOUS; INSULIN; INSULIN INFUSION SYSTEMS; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; QUALITY OF LIFE;

EID: 54449100074     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323000803600531     Document Type: Article

References (10)

1. Hirsch IB: Type 1 diabetes mellitus and the use of flexible insulin regimens. Am Fam Physician 1999; 60: 2343-2352, 2355-2356.
2. Rabasa-Lhoret R, Garon J, Langelier H, et al: Effects of meal carbohydrate content on insulin requirements in type 1 diabetic patients treated intensively with the basal/bolus (ultralente/regular) insulin regimen. Diabetes Care 1999; 22: 667-673.
3. Pickup J, Keen H: Continuous subcutaneous insulin infusion at 25 years: evidence base for the expanding use of insulin pump therapy in type 1 diabetes. Diabetes Care 2002; 25: 593-598.
4. Bode BW, Sabbah HT, Gross TM, et al: Diabetes management in the new millennium using insulin pump therapy. Diabetes Metab Res Rev 2002; 18(suppl 1): S14-S20.
5. Linkeschova R, Raoul M, Bott U, et al: Less severe hypoglycaemia, better metabolic control, and improved quality of life in type 1 diabetes mellitus with continuous subcutaneous insulin infusion (CSII) therapy; an observational study of 100 consecutive patients followed for a mean of 2 years. Diabet Med 2002; 19: 746-751.
6. Gross TM, Kayne D, King A, et al: A bolus calculator is an effective means of controlling postprandial glycemia in patients on insulin pump therapy. Diabetes Technol Ther 2003: 5: 365-369.
7. Jones SM, Quarry JL, Caldwell-McMillan M, et al: Optimal insulin pump dosing and postprandial glycemia following a pizza meal using the continuous glucose monitoring system. Diabetes Technol Ther 2005; 7: 233-240.
8. Deiss D, Bolinder J, Riveline JP, et al: Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 2006; 29: 2730-2732.
9. Marcus AO, Fernandez MP: Insulin pump therapy: acceptable alternative to injection therapy. Postgrad Med 1996; 3: 125-132, 142-144.
10. Lenhard MJ: A new look at patient selection criteria for continuous subcutaneous insulin infusion (CSII). Diabetes Res Clin Pract 2006; 74(suppl 2): S140-S143.